NCT00232011 Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT00231998 Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT00230074 A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS) Status COMPLETED Phase PHASE2
NCT00228059 An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder. Status COMPLETED Phase PHASE3
NCT00228020 Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients Status COMPLETED Phase PHASE3
NCT00226954 Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer Status TERMINATED Phase PHASE2
NCT00226707 Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis Status COMPLETED Phase PHASE3
NCT00222144 Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00219765 Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00219752 Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years Status COMPLETED Phase PHASE2
NCT00219726 Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00219323 Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma. Status COMPLETED Phase PHASE3
NCT00219310 RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir Status COMPLETED Phase PHASE4
NCT00219258 Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00219245 An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits Status COMPLETED Phase PHASE4
NCT00219232 An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease Status COMPLETED Phase PHASE3